Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy

被引:65
|
作者
Gramatges, Maria M. [1 ]
Bertuch, Alison A. [1 ]
机构
[1] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA
关键词
BONE-MARROW FAILURE; PRIMITIVE HEMATOPOIETIC-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; MAINTENANCE COMPONENT 1; REVERSE-TRANSCRIPTASE; HUMAN CST; CEREBELLAR HYPOPLASIA; GENOMIC INSTABILITY; DUPLEX REPLICATION; END-PROTECTION;
D O I
10.1016/j.trsl.2013.05.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Telomeres are DNA-protein structures that form a protective cap on chromosome ends. As such, they prevent the natural ends of linear chromosomes from being subjected to DNA repair activities that would result in telomere fusion, degradation, or recombination. Both the DNA and protein components of the telomere are required for this essential function, because insufficient telomeric DNA length, loss of the terminal telomeric DNA structure, or deficiency of key telomere-associated factors may elicit a DNA damage response and result in cellular senescence or apoptosis. In the setting of failed checkpoint mechanisms, such DNA-protein defects can also lead to genomic instability through telomere fusions or recombination. Thus, as shown in both model systems and in humans, defects in telomere biology are implicated in cellular and organismal aging as well as in tumorigenesis. Bone marrow failure and malignancy are 2 life-threatening disease manifestations in the inherited telomere biology disorder dyskeratosis congenita. We provide an overview of basic telomere structure and maintenance. We outline the telomere biology defects observed in dyskeratosis congenita, focusing on recent discoveries in this field. Last, we review the evidence of how telomere biology may impact sporadic aplastic anemia and the risk for various cancers.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 50 条
  • [21] Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report
    Huang, HM
    Yu, WL
    Huang, YL
    Hwang, WS
    Tsao, CJ
    Liu, HS
    Huang, GC
    CHINESE MEDICAL JOURNAL, 2005, 118 (09) : 790 - 792
  • [22] Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report
    Hsiu-Mei Huang
    Wei-Shiou Hwang
    Chao-Jung Tsao
    Hsiao-Sheng Liu
    ChineseMedicalJournal, 2005, (09) : 790 - 792
  • [23] Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report
    Hsiu-Mei Huang
    Wei-Shiou Hwang
    Chao-Jung Tsao
    Hsiao-Sheng Liu
    中华医学杂志(英文版), 2005, (09) : 790 - 792
  • [24] Aplastic anemia and features of Dyskeratosis Congenita in DKC1 mutant mice.
    Ruggero, D
    Piazza, F
    Rego, E
    Grisendi, S
    Mari, F
    Carlos, CC
    Pandolfi, PP
    BLOOD, 2001, 98 (11) : 838A - 838A
  • [25] DYSKERATOSIS CONGENITA - RELATIONSHIP TO FANCONIS ANEMIA
    VANVOOLE.GA
    STEIER, W
    SELMANOW.VJ
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (06): : 835 - &
  • [26] The biology and management of dyskeratosis congenita and related disorders of telomeres
    Tummala, Hemanth
    Walne, Amanda
    Dokal, Inderjeet
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (08) : 685 - 696
  • [27] Distinguishing Childhood Non-Severe Aplastic Anemia from Dyskeratosis Congenita through Telomere Length Analysis
    Yin, Zixi
    Zhu, Xiaofan
    Wan, Yang
    Gao, Yangyang
    Li, Jun
    BLOOD, 2024, 144 : 1322 - 1323
  • [28] DYSKERATOSIS CONGENITA - RELATIONSHIP TO FANCONIS ANEMIA
    STEIER, W
    SELMANOWITZ, VJ
    VANVOOLE.GA
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 39 (04): : 510 - +
  • [29] The mode of inheritance' in differentiation of Fanconi anemia from Dyskeratosis congenita
    Aslan, Deniz
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2008, 13 (11): : E681 - E682
  • [30] Dyskeratosis congenita: its link to telomerase and aplastic anaemia
    Dokal, I
    Vulliamy, T
    BLOOD REVIEWS, 2003, 17 (04) : 217 - 225